Bexsero Dosage
Generic name: NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN 50ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN 50ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN 50ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE ANTIGEN 25ug in 0.5mL
Dosage form: suspension, for intramuscular injection
Drug class: Bacterial vaccines
Medically reviewed by Drugs.com. Last updated on Aug 19, 2024.
For intramuscular use.
Dose and Schedule
Two-dose schedule: Administer a dose (0.5 mL) at 0 and 6 months. If the second dose is administered earlier than 6 months after the first dose, a third dose should be administered at least 4 months after the second dose.
Three-dose schedule: Administer a dose (0.5 mL) at 0, 1-2, and 6 months.
The choice of dosing schedule may depend on the risk of exposure and the individual’s susceptibility to meningococcal serogroup B disease.
Administration
Shake the syringe immediately before use to form a homogeneous suspension. Do not use the vaccine if it cannot be resuspended. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not use if particulate matter or discoloration is found.
Administer BEXSERO as a 0.5-mL intramuscular injection.
More about Bexsero (meningococcal group B vaccine)
- Check interactions
- Compare alternatives
- Side effects
- During pregnancy
- FDA approval history
- Drug class: bacterial vaccines
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.